Skip to main content
. 2017 Aug 3;7:7240. doi: 10.1038/s41598-017-07655-1

Figure 4.

Figure 4

Confirmation of MRE on DYRK1A promoter by EMSA and ChIP. (A) The consensus MEF2 oligonucleotides were labelled with infrared fluorescence IRDye® 700 and used as probes. EMSA was performed as described in methods. DY-MRE is the oligonucleotide of −282 bp to −251 bp from DYRK1A promoter. Numbers of competitor indicates the molar excess of labelled oligonucleotides. (B) DY-MRE was labelled with infrared fluorescence IRDye® 700 IRDye. EMSA was performed as described in methods. Anti-MEF2D antibody was used in supershift. (C) ChIP was used to confirm the binding of MEF2D with DYRK1A promoter region. Anti-MEF2D antibody, anti-RNA Polymerase II and normal mouse IgG were used in chromatin immunoprecipitation from HEK293 cells. Primers to amplify a short DNA sequence spanning the putative DY-MRE site in DYRK1A promoter region and GAPDH were used for PCR. IgG and H2O were used as the negative controls. (D) Western blot showed that the anti-MEF2D antibody actually immunoprecipitated MEF2D protein. The lower bands were antibody heavy chain.